MétaCan
Menu
Back to cohort
Record W4412796687 · doi:10.1016/j.neurot.2025.e00690

Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study

2025· article· en· W4412796687 on OpenAlexaff
Katharina Strempfl, Marco Zattoni, Heike Mrowetz, Michael S. Unger, Nikolaos Schörghofer, Barbara Altendorfer, Joerg Neddens, Stefanie Flunkert, Birgit Hutter‐Paier, Yachao He, Johan Wallin, Rodolphe Poupardin, Frank Pietrantonio, Nadine Paiement, Horst Zerbe, Thomas K. Felder, Per Svenningsson, Ludwig Aigner

Bibliographic record

VenueNeurotherapeutics · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsCentre Intégré de Santé et de Services Sociaux des Laurentides
FundersÖsterreichische ForschungsförderungsgesellschaftAustrian Science Fund
KeywordsNeuroinflammationNeurologyParkinson's diseaseMedicineNeuroscienceDiseaseMontelukastPhysical medicine and rehabilitationPsychologyInternal medicine

Abstract

fetched live from OpenAlex

Parkinson's disease (PD) is a neurodegenerative movement disorder of high global burden. Uncertainties regarding its exact etiology have been hindering the development of curative therapies. As microglia, the brain's immune cells, are suspected to contribute to neurodegeneration by instigating neuroinflammation, existing anti-inflammatory agents could potentially serve as disease-modifying treatments for PD. Here we evaluated the impact of montelukast, a leukotriene receptor antagonist and anti-inflammatory drug, on motor symptoms and neuropathology in an α-synuclein transgenic mouse model (Line 61) for early onset/genetic PD. Two -weeks -old male Line 61 mice and non-transgenic littermates received daily 10 ​mg/kg montelukast or vehicle orally for 10 weeks. Motor functions were assessed through behavioral tests. Brain tissue was analyzed via unbiased transcriptomics, biochemically, and histologically for various parameters, including microglial and inflammation mediators. Upon montelukast treatment, Line 61 mice significantly improved their beam walk performance compared to vehicle -treated mice. The striatum and cerebellum of the montelukast -treated group showed microglial changes toward a smaller but more ramified appearance. Transcriptomics analysis revealed SGK1, a serine/threonine kinase upstream of NFκB and known target in PD, as the most downregulated gene in the striatum of montelukast -treated animals. This downregulation correlated with reduced striatal protein levels of activated IκB kinase, suggesting a reduced NFκB pathway activity upon montelukast treatment. Thus, oral montelukast administration might be promising for the management of PD, with specific effects on motor coordination and balance.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.207
Threshold uncertainty score0.509

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.294
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeurotherapeuticsSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207